Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Letrozole
Sponsor: Novartis Pharmaceuticals